Emerald Medical Applications (OTC: MRLA) owns the Dermacompare Medical App, a cloud-based, artificial intelligence technology that enables photos, taken from almost all digital cameras, to detect the suspicion of melanoma. The FDA-registered, HIPPA-compliant app, available from any App store, enables the user to identify suspicious melanoma moles automatically by comparing the photos to Emerald’s cloud database of over 50 million known moles, as well as the patient’s previous pictures. For more information, visit the company’s website at www.dermacompare.com